Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?

BACKGROUND: Globally, enteric-coated mycophenolate sodium (EC-MPS) is replacing mycophenolate mofetil (MMF) in maintenance immunosuppressant regimens. The predominant reason for conversion is the purported improvement in gastrointestinal (GI) quality of life. This paper considers the level of bias a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gardiner, Kyle M., Tett, Susan E., Staatz, Christine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277323/
https://www.ncbi.nlm.nih.gov/pubmed/30426342
http://dx.doi.org/10.1007/s40268-018-0254-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277323/
https://www.ncbi.nlm.nih.gov/pubmed/30426342
http://dx.doi.org/10.1007/s40268-018-0254-8

Ejemplares similares